These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26981193)

  • 1. Yersinia type III effectors perturb host innate immune responses.
    Pha K; Navarro L
    World J Biol Chem; 2016 Feb; 7(1):1-13. PubMed ID: 26981193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The virulence plasmid of Yersinia, an antihost genome.
    Cornelis GR; Boland A; Boyd AP; Geuijen C; Iriarte M; Neyt C; Sory MP; Stainier I
    Microbiol Mol Biol Rev; 1998 Dec; 62(4):1315-52. PubMed ID: 9841674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-Function Analysis Reveals Important Virulence Roles for the Yersinia pestis Type III Secretion System Effectors YopJ, YopT, and YpkA.
    Palace SG; Proulx MK; Szabady RL; Goguen JD
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
    Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
    Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation.
    Ratner D; Orning MP; Proulx MK; Wang D; Gavrilin MA; Wewers MD; Alnemri ES; Johnson PF; Lee B; Mecsas J; Kayagaki N; Goguen JD; Lien E
    PLoS Pathog; 2016 Dec; 12(12):e1006035. PubMed ID: 27911947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
    Auerbuch V; Golenbock DT; Isberg RR
    PLoS Pathog; 2009 Dec; 5(12):e1000686. PubMed ID: 19997504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.
    Viboud GI; Bliska JB
    Annu Rev Microbiol; 2005; 59():69-89. PubMed ID: 15847602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
    Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
    mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Rho GTPases by type III secretion system translocated effectors of Yersinia.
    Aepfelbacher M
    Rev Physiol Biochem Pharmacol; 2004; 152():65-77. PubMed ID: 15378389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils are resistant to Yersinia YopJ/P-induced apoptosis and are protected from ROS-mediated cell death by the type III secretion system.
    Spinner JL; Seo KS; O'Loughlin JL; Cundiff JA; Minnich SA; Bohach GA; Kobayashi SD
    PLoS One; 2010 Feb; 5(2):e9279. PubMed ID: 20174624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of Interleukin-1β and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence.
    Ratner D; Orning MP; Starheim KK; Marty-Roix R; Proulx MK; Goguen JD; Lien E
    J Biol Chem; 2016 May; 291(19):9894-905. PubMed ID: 26884330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.
    Chung LK; Park YH; Zheng Y; Brodsky IE; Hearing P; Kastner DL; Chae JJ; Bliska JB
    Cell Host Microbe; 2016 Sep; 20(3):296-306. PubMed ID: 27569559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM.
    Chung LK; Philip NH; Schmidt VA; Koller A; Strowig T; Flavell RA; Brodsky IE; Bliska JB
    mBio; 2014 Jul; 5(4):e01402-14. PubMed ID: 24987096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense.
    Cornelis GR
    Folia Microbiol (Praha); 1998; 43(3):253-61. PubMed ID: 9717252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
    Sheahan KL; Isberg RR
    mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells.
    Iriarte M; Cornelis GR
    Mol Microbiol; 1998 Aug; 29(3):915-29. PubMed ID: 9723929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Functions of Effector Proteins in Yersinia Virulence.
    Zhang L; Mei M; Yu C; Shen W; Ma L; He J; Yi L
    Pol J Microbiol; 2016; 65(1):5-12. PubMed ID: 27281989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Rho GTPases and the actin cytoskeleton by Yersinia outer proteins (Yops).
    Aepfelbacher M; Heesemann J
    Int J Med Microbiol; 2001 Sep; 291(4):269-76. PubMed ID: 11680787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cell biology aspects of plague.
    Cornelis GR
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8778-83. PubMed ID: 10922034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.